COVID-19 has placed an enormous strain on the healthcare systems of the nations where it has spread widely, with specific implications of the disease on practice in the catheterization laboratory.
Catheter-based renal denervation was superior to a sham procedure for reducing BP in the absence of antihypertensive medications in patients with uncontrolled hypertension, according to results of the SPYRAL HTN-OFF MED pivotal trial.
As part of its global response to the growing COVID-19 pandemic, the American Heart Association, the world’s leading voluntary organization focused on heart and brain health and research, is committing $2.5 million to research efforts to better understand this unique coronavirus and its interaction with the body’s cardiovascular and cerebrovascular systems.
James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.
Higher habitual physical activity as measured by a smartwatch is associated with lower home blood pressure levels, but body mass index (BMI) might account for the majority of that relationship, according to a new study.
Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2.
The US Food and Drug Administration (FDA) has issued an immediately-in-effect guidance that allows manufacturers of certain FDA-cleared non-invasive, vital-sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely.
Fewer than 40% of patients with a diagnosis of new-onset heart failure are being evaluated for CAD during the index hospitalization, according to a large analysis of Medicare recipients.
The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective surgeries, non-essential medical procedures and dental procedures should be delayed during the novel coronavirus (COVID-19, SARS-CoV-2) outbreak.
Patients undergoing PCI for chronic total occlusion (CTO) lesions have poorer outcomes and more complex procedures if they have previously undergone CABG surgery than if they have not, according to results of a new meta-analysis.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!